Fjaras, Sweden

Nils Olov Ingemar Nilsson

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nils Olov Ingemar Nilsson. Retrieved from https://idiyas.com/inventor/nils-olov-ingemar-nilsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nils Olov Ingemar Nilsson: Innovator in Pharmaceutical Preparations

Introduction

Nils Olov Ingemar Nilsson is a notable inventor based in Fjärås, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on peptide derivatives. His research and inventions have the potential to impact medical treatments and drug formulations.

Latest Patents

Nils holds a patent for a pharmaceutical preparation that contains an effective amount of acetylsalicylic acid and a compound of Formula I.A—A—NH—(CH)—B. This patent showcases his expertise in developing new pharmaceutical solutions that could enhance therapeutic efficacy.

Career Highlights

Nils is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Throughout his career, Nils has worked alongside talented colleagues, including Karl Thomas Antonsson and Ruth Elvy Bylund. These collaborations have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical science.

Conclusion

Nils Olov Ingemar Nilsson is a distinguished inventor whose work in pharmaceutical preparations exemplifies the importance of innovation in medicine. His contributions continue to pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…